Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma – Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center. Issue 5 (October 2019)

Record Type:: Journal Article
Title:: Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma – Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center. Issue 5 (October 2019)
Main Title:: Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma – Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center
Authors:: Momotow, Jesko
Goergen, Helen
Behringer, Karolin
Bröckelmann, Paul J.
Borchmann, Sven
Tresckow, Bastian v.
Kobe, Carsten
Engert, Andreas
Sasse, Stephanie
Abstract:
Is Part Of:: HemaSphere. Volume 3:Issue 5(2019)
Journal:: HemaSphere
Issue:: Volume 3:Issue 5(2019)
Issue Display:: Volume 3, Issue 5 (2019)
Year:: 2019
Volume:: 3
Issue:: 5
Issue Sort Value:: 2019-0003-0005-0000
Page Start:
Page End:
Publication Date:: 2019-10
Subjects:: Hematology -- Periodicals
616.15005
Journal URLs:: https://journals.lww.com/hemasphere/pages/default.aspx ↗
http://journals.lww.com/pages/default.aspx ↗
DOI:: 10.1097/HS9.0000000000000293 ↗
Languages:: English
ISSNs:: 2572-9241
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 16440.xml